503
Participants
Start Date
February 19, 2013
Primary Completion Date
June 18, 2018
Study Completion Date
January 28, 2019
Placebo plus standard therapy
Placebo plus standard therapy
Belimumab 10 mg/kg plus standard therapy
Belimumab 10mg/kg plus standard therapy
Standard therapy
Standard therapy comprises any of the following (alone or in combination): corticosteroids, antimalarials, non-steroidal anti-inflammatory drugs (NSAIDs), and immunosuppressives; biologics and intravenous cyclophosphamide are not permitted.
GSK Investigational Site, Medellín
GSK Investigational Site, Diepkloof
GSK Investigational Site, Johannesburg
GSK Investigational Site, Durban
GSK Investigational Site, Panorama / Cape Town
GSK Investigational Site, New York
GSK Investigational Site, New York
GSK Investigational Site, New York
GSK Investigational Site, Great Neck
GSK Investigational Site, Manhasset
GSK Investigational Site, Brooklyn
GSK Investigational Site, Brooklyn
GSK Investigational Site, Brooklyn
GSK Investigational Site, Wyomissing
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Chapel Hill
GSK Investigational Site, Raleigh
GSK Investigational Site, Greenville
GSK Investigational Site, Charlotte
GSK Investigational Site, Wilmington
GSK Investigational Site, Columbia
GSK Investigational Site, Columbia
GSK Investigational Site, Charleston
GSK Investigational Site, Duluth
GSK Investigational Site, Atlanta
GSK Investigational Site, DeBary
GSK Investigational Site, Longwood
GSK Investigational Site, Orlando
GSK Investigational Site, Miami Lakes
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Aventura
GSK Investigational Site, Tamarac
GSK Investigational Site, Plantation
GSK Investigational Site, Fort Lauderdale
GSK Investigational Site, Tampa
GSK Investigational Site, Birmingham
GSK Investigational Site, Memphis
GSK Investigational Site, Memphis
GSK Investigational Site, Jackson
GSK Investigational Site, Jackson
GSK Investigational Site, Columbus
GSK Investigational Site, Cleveland
GSK Investigational Site, Detroit
GSK Investigational Site, Lansing
GSK Investigational Site, Chicago
GSK Investigational Site, St Louis
GSK Investigational Site, Baton Rouge
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Dallas
GSK Investigational Site, Houston
GSK Investigational Site, Houston
GSK Investigational Site, The Woodlands
GSK Investigational Site, Austin
GSK Investigational Site, Austin
GSK Investigational Site, Las Vegas
GSK Investigational Site, Las Vegas
GSK Investigational Site, Los Angeles
GSK Investigational Site, La Palma
GSK Investigational Site, Lakewood
GSK Investigational Site, Los Alamitos
GSK Investigational Site, Covina
GSK Investigational Site, Upland
GSK Investigational Site, Murrieta
GSK Investigational Site, Fort de France
GSK Investigational Site, Bucaramanga
GSK Investigational Site, Santiago de Cali
GSK Investigational Site, Porto Alegre
GSK Investigational Site, Bridgeport
GSK Investigational Site, Orlando
GSK Investigational Site, Boston
GSK Investigational Site, Clifton
GSK Investigational Site, Dallas
GSK Investigational Site, Arlington
GSK Investigational Site, Salvador
GSK Investigational Site, Cuiabá
GSK Investigational Site, Juiz de Fora
GSK Investigational Site, Curitba
GSK Investigational Site, Porto Alegre
GSK Investigational Site, Porto Alegre
GSK Investigational Site, Campinas
GSK Investigational Site, Santo André
GSK Investigational Site, Belo Horizonte, Minas Gerais
GSK Investigational Site, Campo Grande
GSK Investigational Site, Rio de Janeiro
GSK Investigational Site, São Paulo
GSK Investigational Site, São Paulo
GSK Investigational Site, São Paulo
GSK Investigational Site, São Paulo
GSK Investigational Site, Barranquilla
GSK Investigational Site, Basildon
GSK Investigational Site, London
GSK Investigational Site, London
GSK Investigational Site, London
GSK Investigational Site, Manchester
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Human Genome Sciences Inc., a GSK Company
INDUSTRY